The precision medical imaging market is expected to grow from $120 million in 2017 to more than $8 billion in 2027, according to new analysis from Frost & Sullivan.
The full Frost & Sullivan report, Growth Opportunities in Precision Medical Imaging, Forecast to 2022, examines this topic in significant detail.
“Precision medical imaging has tremendous potential to improve all aspects of the care continuum, thus supporting emerging care approaches that are more targeted, predictive, translational, personalized and effective,” Siddharth Saha, vice president of research, transformational health, said in a prepared statement. “AI-enriched imaging equipment will help adapt and personalize the imaging protocols and procedures while precise radiomic and phenomic datasets from the given clinical context will enable deep learning, thereby reinforcing medical imaging's contribution to precision medicine. There are several firms in the ecosystem making very valuable contributions to the care pathways and this pool is set to exponentially grow in the short term.”
The consulting firm’s statement also examines 10 growth opportunities in the precision medical imaging space:
- Evidence-based study ordering
- Advanced imaging techniques and personalized image acquisition protocols
- Machine intelligence
- Precision reporting
- Quantitative imaging and radiomics
- Image-based, 3D-printed implants and anatomical guides
- Real-time, image-guided interventions
- Precise oncologic radiation dose therapy
- Molecular imaging of theranostic radiotracers
- Imaging study volume, quality and outcomes analytics
The full report is available on Frost & Sullivan’s website.